Ten-year risks of recurrent stroke, disability, dementia and cost in relation to site of primary intracerebral haemorrhage: population-based study
Open Access
- 12 March 2020
- journal article
- research article
- Published by BMJ in Journal of Neurology, Neurosurgery & Psychiatry
- Vol. 91 (6), 580-585
- https://doi.org/10.1136/jnnp-2019-322663
Abstract
Background Patients with primary intracerebral haemorrhage (ICH) are at increased long-term risks of recurrent stroke and other comorbidities. However, available estimates come predominantly from hospital-based studies with relatively short follow-up. Moreover, there are also uncertainties about the influence of ICH location on risks of recurrent stroke, disability, dementia and quality of life. Methods In a population-based study (Oxford Vascular Study/2002–2018) of patients with a first ICH with follow-up to 10 years, we determined the long-term risks of recurrent stroke, disability, quality of life, dementia and hospital care costs stratified by haematoma location. Results Of 255 cases with primary ICH (mean/SD age 75.5/13.1), 109 (42.7%) had lobar ICH, 144 (56.5%) non-lobar ICH and 2 (0.8%) had uncertain location. Annual rates of recurrent ICH were higher after lobar versus non-lobar ICH (lobar=4.0%, 2.7–7.2 vs 1.1%, 0.3–2.8; p=0.02). Moreover, cumulative rate of dementia was also higher for lobar versus non-lobar ICH (n/% lobar=20/36.4% vs 16/20.8%, p=0.047), and there was a higher proportion of disability at 5 years in survivors (15/60.0% vs 9/31.0%, p=0.03). The 10-year quality-adjusted life years (QALYs) were also lower after lobar versus non-lobar ICH (2.9 vs 3.8 for non-lobar, p=0.04). Overall, the mean 10-year censor-adjusted costs were £19 292, with over 80% of costs due to inpatient hospital admission costs, which did not vary by haematoma location (p=0.90). Conclusion Compared with non-lobar ICH, the substantially higher 10-year risks of recurrent stroke, dementia and lower QALYs after lobar ICH highlight the need for more effective prevention for this patient group.Funding Information
- National Institute for Health Research
- Oxford Biomedical Research Centre
- British Heart Foundation
- Wolfson Foundation
- Wellcome Trust
This publication has 34 references indexed in Scilit:
- Five-Year Risk of Major Ischemic and Hemorrhagic Events After Intracerebral HemorrhageStroke, 2019
- Long-term prognosis after intracerebral haemorrhage: systematic review and meta-analysisJournal of Neurology, Neurosurgery & Psychiatry, 2013
- Incidence, case fatality, and functional outcome of intracerebral haemorrhage over time, according to age, sex, and ethnic origin: a systematic review and meta-analysisThe Lancet Neurology, 2010
- Three-Year Survival and Stroke Recurrence Rates in Patients With Primary Intracerebral HemorrhageStroke, 2009
- Change in incidence and aetiology of intracerebral haemorrhage in Oxfordshire, UK, between 1981 and 2006: a population-based studyThe Lancet Neurology, 2007
- Antiplatelet use after intracerebral hemorrhageNeurology, 2006
- Recurrent primary intracerebral hemorrhage in Izumo City, JapanSurgical Neurology, 2005
- Change in stroke incidence, mortality, case-fatality, severity, and risk factors in Oxfordshire, UK from 1981 to 2004 (Oxford Vascular Study)The Lancet, 2004
- Rate of Stroke Recurrence in Patients With Primary Intracerebral HemorrhageStroke, 2000
- Recurrence of Bleeding in Patients With Primary Intracerebral HemorrhageStroke, 1995